| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
intraperitoneal-dog LD > 410 mg/kg Antibiotiki i Khimioterapiya. Antibiotics and Chemotherapy. Vol. 33, Pg. 666, 1988.
intraperitoneal-mouse LD > 5500 mg/kg Antibiotiki i Khimioterapiya. Antibiotics and Chemotherapy. Vol. 33, Pg. 666, 1988.
intraperitoneal-rat LD > 2000 mg/kg Antibiotiki i Khimioterapiya. Antibiotics and Chemotherapy. Vol. 33, Pg. 666, 1988.
|
| Dermal Toxicity: |
subcutaneous-dog LD > 410 mg/kg Antibiotiki i Khimioterapiya. Antibiotics and Chemotherapy. Vol. 33, Pg. 666, 1988.
subcutaneous-mouse LD > 5500 mg/kg Antibiotiki i Khimioterapiya. Antibiotics and Chemotherapy. Vol. 33, Pg. 666, 1988.
subcutaneous-rat LD > 2000 mg/kg Antibiotiki i Khimioterapiya. Antibiotics and Chemotherapy. Vol. 33, Pg. 666, 1988.
|
| Inhalation Toxicity: |
|
Not determined
|